Mukka Proteins Q4 FY26: Revenue ₹381.6 Cr, PAT ₹21.4 Cr
Q4 FY26 investor presentation: what the company reported on revenue, margins and capex.
- Revenue
- ₹381Cr
- −0.3% YoY
- Net profit
- ₹21Cr
- +50% YoY
- Margin
- 9%
- +1 pp YoY
Top 10 Food Products companies on management guidance
See the sector's top 10 — free with your mobile number.
Based on Mukka Proteins Ltd's Q4 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q4 FY26 Revenue from Operations: ₹381.6 Cr. Q4 FY26 Revenue from operations: ₹381.6 Cr (up from ₹380.6 Cr in Q4 FY25).
From Mukka Proteins Ltd's Q4 FY26 earnings-call transcript · updated 25 Sept 2026.
Revenue & Sales Performance
- Q4 FY26 Revenue from Operations: ₹381.6 Cr
- Q4 FY25 Revenue from Operations: ₹380.6 Cr
- Year-on-Year (Q4) Revenue Growth: Slight increase of ₹1 Cr (~0.26%) from Q4 FY25 to Q4 FY26
- FY26 Revenue from Operations: ₹1,449.5 Cr
- FY25 Revenue from Operations: ₹1,006.4 Cr
- Year-on-Year (FY) Revenue Growth: ₹443.1 Cr (approx. 44%) increase from FY25 to FY26
- Explicit Revenue Outlook:
2 more points from Mukka Proteins Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Mukka Proteins Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Bengaluru Leachate Treatment Project
- CAPEX: ~₹100 Cr
- Order Value: ₹474.89 Cr (ex-GST)
- JV Stake: 76%
- Timeline: ~6 months construction; 4-year project
- Client: Bengaluru Solid Waste Management Ltd (BSWML)
- Oman Facility Expansion
- Location: Aljoubah Industrial Area, Oman
- Plant Size: 21,249 sq. mt
2 more points from Mukka Proteins Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Food Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Mukka Proteins Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Mukka Proteins Ltd's call on order book
Create a free account to keep reading this call
Mukka Proteins Ltd — Quarterly revenue & net profit
Mukka Proteins Ltd Q4 FY26 results — key figures
| ₹ Cr | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 381 | 382 | -0.3% | 654 | -41.7% |
| Operating profit (EBITDA) | 34 | 29 | +17.2% | 45 | -24.4% |
| Operating margin | 9% | 8% | +1 pp | 7% | +2 pp |
| Profit before tax | 29 | 20 | +45% | 35 | -17.1% |
| Net profit (PAT) | 21 | 14 | +50% | 27 | -22.2% |
| EPS (₹) | 0.69 | 0.45 | +53.3% | 0.79 | -12.7% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹509 Cr, net profit ₹18 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Mukka Proteins's management said in earlier quarters
Others in Food Products this season
- HMA Agro Industries (Q4 FY26)
The company remains confident about sustaining a 25%-30% growth rate in revenue, supported by increased utilization and higher value-added product contribution…
- Coastal Corporat (Q4 FY26)
Total Income from Operations: ₹728.75 Cr . Key investor presentation takeaways from Coastal Corporat's Q4 FY26 investor presentation — and how it ranks against
- Megastar Foods (Q4 FY26)
Q4FY26 Revenue from Operations: ₹14,606 lakhs (Page 7) . Key investor presentation takeaways from Megastar Foods's Q4 FY26 investor presentation — and how it ra
- Shri Ahimsa (Q4 FY26)
Revenue figures (₹ in Crs) for FY: . Key concall takeaways from Shri Ahimsa Naturals Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.
Potential multibaggers · Q2 FY27
Potential multibaggers in Food Products
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Mukka Proteins Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Mukka Proteins Ltd Q4 FY26 results?
Q4 FY26 Revenue from Operations: ₹381.6 Cr. Q4 FY26 Revenue from operations: ₹381.6 Cr (up from ₹380.6 Cr in Q4 FY25).
What is Mukka Proteins Ltd share price analysis?
Mukka Proteins Ltd currently shows a neutral. The stock trades at a P/E of 11.7 with a market cap of ₹808 Cr. Investors should review the full earnings analysis for detailed insights.
Is Mukka Proteins Ltd planning capital expenditure?
Bengaluru Leachate Treatment Project - CAPEX: ~₹100 Cr - Order Value: ₹474.89 Cr (ex-GST) - JV Stake: 76% - Timeline: ~6 months construction; 4-year project - Client: Bengaluru Solid Waste Management Ltd (BSWML) - Oman Facility Expansion - Location: Aljoubah Industrial Area, Oman - Plant Size: 21,249 sq.
Keep Mukka Proteins Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.